Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Oct 11:19:1212-1215.
doi: 10.12659/AJCR.910600.

Hepatic Involvement in Systemic Sarcoidosis

Affiliations
Case Reports

Hepatic Involvement in Systemic Sarcoidosis

Abdisamad M Ibrahim et al. Am J Case Rep. .

Abstract

BACKGROUND Sarcoidosis is a systemic disease that can affect any organ, including the liver. It is manifested by the presence of non-caseating granulomas within involved organs, most commonly the pulmonary, lymphatic, and hepatic system. Unlike pulmonary or lymphatic involvement, hepatic involvement is usually asymptomatic and it is underdiagnosed. Here, we report a case of a patient with a history of pulmonary sarcoidosis who developed hepatic sarcoidosis. CASE REPORT 68-year-old female with pulmonary sarcoidosis with a 2-week history of severe abdominal pain and epigastric tenderness presented to our center. Abdominal magnetic resonance imaging (MRI) demonstrated mild hepatic fibrosis and cirrhosis. A thorough workup was performed including a liver biopsy which showed chronic non-necrotizing granulomas consistent with sarcoidosis. She was started on prednisone and subsequently improved. The patient was symptom-free on follow-up 1 month later. CONCLUSIONS The majority of patients with hepatic sarcoidosis are usually asymptomatic, with only 5-30% presenting with abdominal pain, jaundice, nausea, vomiting, and hepatosplenomegaly. In rare cases, hepatic sarcoidosis can lead to cholestasis, portal hypertension, cirrhosis, or Budd-Chiari syndrome. Treatment with steroids is the mainstay of therapy; however, in severe cases, patients may require liver transplantation. This case report demonstrates that hepatic sarcoidosis is a serious condition, and if not treated, can lead to portal hypertension and cirrhosis. In patients with sarcoidosis, early detection and longitudinal follow-up is important in preventing overt liver failure.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Conflict of interest

None.

Figures

Figure 1.
Figure 1.
(A) Coronal view of abdominal magnetic resonance imaging (MRI). MRI demonstrates mild fibrosis and cirrhosis in the liver. Hepatosplenomegaly is appreciated on this image as well. (B) Chest computed tomography (CT) with contrast. CT chest demonstrates calcified granulomas within the lungs.
Figure 2.
Figure 2.
Histopathology. (A) hematoxylin and eosin section showing chronic granulomatous hepatitis with compact non-necrotizing granulomas. Notice the absence stainable iron in the hepatocytes with the trichrome stain (B).

References

    1. Tan CB, Rashid S, Rajan D, et al. Hepatic sarcoidosis presenting as portal hypertension and liver cirrhosis: Case report and review of the literature. Case Rep Gastroenterol. 2012;6(1):183–89. - PMC - PubMed
    1. Ayyala US, Padilla ML. Diagnosis and treatment of hepatic sarcoidosis. Curr Treat Options Gastroenterol. 2006;9(6):475–83. - PubMed
    1. Tadros M, Forouhar F, Wu GY. Hepatic sarcoidosis. J Clin Transl Hepatol. 2013;1(2):87–93. - PMC - PubMed
    1. Lannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357:2153–65. - PubMed
    1. Cremers J, Drent M, Driessen A, et al. Liver-test abnormalities in sarcoidosis. Eur J Gastroenterol Hepatol. 2012;24(1):17–24. - PubMed

Publication types